# sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis

> **NCT02702765** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 33 (actual)

## Conditions studied

- Wilsons Disease

## Interventions

- **PROCEDURE:** Fibroscan
- **PROCEDURE:** Ultrasound
- **DRUG:** Galactose
- **PROCEDURE:** Liver biopsy
- **PROCEDURE:** Functional hepatic nitrogen clearance

## Key facts

- **NCT ID:** NCT02702765
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2020-02
- **Final completion:** 2022-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702765, "sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02702765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*